Asset Details
Do you wish to reserve the book?
Zerumbone augments cognitive enhancement potentials of EPA+DHA: insight from a hyperlipidaemic rat model
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Zerumbone augments cognitive enhancement potentials of EPA+DHA: insight from a hyperlipidaemic rat model
Do you wish to request the book?
Zerumbone augments cognitive enhancement potentials of EPA+DHA: insight from a hyperlipidaemic rat model
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Zerumbone augments cognitive enhancement potentials of EPA+DHA: insight from a hyperlipidaemic rat model
2020
Overview
Hyperlipidaemia and cognitive dysfunction (CD) are the two public health concerns. Though hyperlipidaemia has been comprehensively studied in respect to CVD, its role on CD needs to be explored. Hence, we evaluated hyperlipidaemia as a risk factor for CD and the efficacy of EPA (20 : 5n-3) + DHA (22 : 6n-3) and zerumbone (Z) in modulating CD under hyperlipidaemic conditions. Male Wistar rats (Rattus norvegicus) were fed control, high-fat (HF), high-fat + fish oil (HF + F), high-fat + zerumbone (HF+Z) and high-fat + fish oil + zerumbone (HF+F+Z) containing diets. After a 30 d feeding trial, memory parameters (Morris water maze, elevated plus maze (transfer latency) and T-maze (spontaneous alteration)) and locomotor skills (open field test and rotarod test) were assessed. Hyperlipidaemia significantly (P < 0·05) reduced memory and motor coordination skills compared with control. However, the administration of EPA + DHA and zerumbone significantly (P < 0·05) restored the hyperlipidaemia-induced loss of memory and motor coordination skills. Collectively, our data imply that hyperlipidaemia causes CD by decreasing memory and motor coordination skills, and administration of EPA + DHA and zerumbone prevents hyperlipidaemia-induced CD. The augmented effect of EPA + DHA, together with zerumbone, discloses a promising strategy for lowering the severity of CD in hyperlipidaemic conditions.
Publisher
Cambridge University Press
Subject
/ Animals
/ Behaviour, Appetite and Obesity
/ Cognitive Dysfunction - etiology
/ Cognitive Dysfunction - prevention & control
/ Diet
/ Diet, High-Fat - adverse effects
/ Docosahexaenoic Acids - pharmacology
/ Eicosapentaenoic Acid - pharmacology
/ Hyperlipidemias - diet therapy
/ Hyperlipidemias - psychology
/ Latency
/ Male
/ males
/ Memory
/ Nootropic Agents - pharmacology
/ Rats
/ Sesquiterpenes - pharmacology
/ Skills
